211
Views
1
CrossRef citations to date
0
Altmetric
Original research

Identification of risk factors of 30-day readmission and 180-day in-hospital mortality, and its corresponding relative importance in patients with Ischemic heart disease: a machine learning approach

ORCID Icon, , & ORCID Icon
Pages 1043-1048 | Received 14 Aug 2020, Accepted 22 Oct 2020, Published online: 11 Nov 2020

References

  • Kurian AK, Cardarelli KM. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis. 2007;17:143–152.
  • Bonow RO, Grant AO, Jacobs AK. The cardiovascular state of the union: confronting healthcare disparities. Circulation. 2005;111(10):1205–1207.
  • Mensah GA, Mokdad AH, Ford ES, et al. State of disparities in cardiovascular health in the United States. Circulation. 2005;111:1233–1241.
  • McClellan M, Brown N, Califf RM, et al. Call to action: urgent challenges in cardiovascular disease: a presidential advisory from the American Heart Association. Circulation. 2019;139:e44–e54.
  • Centers for Medicare & Medicaid Services. Hospital readmissions reduction program (HRRP); 2019 [cited 2020 Feb]. Available from: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program
  • Santschi V, Chiolero A, Burnand B, et al. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med. 2011;171:1441–1453.
  • Piepoli MF, Hoes AW, Agewall S, et al. European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37:2315–2381. Epub 2016 May 23.
  • Wang N, Gallagher R, Sze D, et al. Predictors of frequent readmissions in patients with heart failure. Heart Lung Circ. 2019;28:277–283.
  • Hernandez MB, Schwartz RS, Asher CR, et al. Predictors of 30-day readmission in patients hospitalized with decompensated heart failure. Clin Cardiol. 2013;36(9):542–547.
  • McNamara RL, Kennedy KF, Cohen DJ, et al. Predicting in-hospital mortality in patients with acute myocardial infarction. J Am Coll Cardiol. 2016;68:626–635.
  • Ranganathan P, Pramesh C, Aggarwal R. Common pitfalls in statistical analysis: logistic regression. Perspect Clin Res. 2017;8:148–151.
  • Bishop CM. Model-based machine learning. Philos Trans A Math Phys Eng Sci. 2013;371:20120222.
  • Deo RC. Machine learning in medicine. Circulation. 2015;132:1920–1930.
  • Sidey-Gibbons JAM, Sidey-Gibbons CJ. Machine learning in medicine: a practical introduction. BMC Med Res Methodol. 2019;19:64.
  • Kakadiaris IA, Vrigkas M, Yen AA, et al. Machine learning outperforms ACC/AHA CVD risk calculator in MESA. J Am Heart Assoc. 2018;7:e009476.
  • Ambale-Venkatesh B, Yang X, Wu CO, et al. Cardiovascular event prediction by machine learning: the multi-ethnic study of atherosclerosis. Circ Res. 2017;121:1092–1101.
  • Morgan DJ, Bame B, Zimand P, et al. Assessment of machine learning vs standard prediction rules for predicting hospital readmissions. JAMA Network Open. 2019;2:e190348–e190348.
  • Mortazavi BJ, Downing NS, Bucholz EM, et al. Analysis of machine learning techniques for heart failure readmissions. Circ Cardiovasc Qual Outcomes. 2016;9:629–640.
  • Steele AJ, Denaxas SC, Shah AD, et al. Machine learning models in electronic health records can outperform conventional survival models for predicting patient mortality in coronary artery disease. PLoS One. 2018;13:e0202344.
  • Al’Aref SJ, Anchouche K, Singh G, et al. Clinical applications of machine learning in cardiovascular disease and its relevance to cardiac imaging. Eur Heart J. 2019;40:1975–1986.
  • Goldstein BA, Navar AM, Carter RE. Moving beyond regression techniques in cardiovascular risk prediction: applying machine learning to address analytic challenges. Eur Heart J. 2017;38:1805–1814.
  • Preen DB, Holman CD, Spilsbury K, et al. Length of comorbidity lookback period affected regression model performance of administrative health data. J Clin Epidemiol. 2006;59:940–946. Epub 2006 Jun 19.
  • Tripathi A, Abbott JD, Fonarow GC, et al. Thirty-day readmission rate and costs after percutaneous coronary intervention in the United States. Circ Cardiovasc Interv. 2017;10(12). DOI:https://doi.org/10.1161/CIRCINTERVENTIONS.117.005925
  • Wadhera RK, Joynt Maddox KE, Wasfy JH, et al. Association of the hospital readmissions reduction program with mortality among medicare beneficiaries hospitalized for heart failure, acute myocardial infarction, and pneumonia. JAMA. 2018;320:2542–2552.
  • Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36:1–10.
  • Van den Broeck J, Cunningham SA, Eeckels R, et al. Data cleaning: detecting, diagnosing, and editing data abnormalities. PLoS Med. 2005;2:e267.
  • Grafarend EW. Linear and nonlinear models: fixed effects, random effects, and mixed models. Berlin, NY: Walter de Gruyter; 2006.
  • Chawla NV, Bowyer KW, Hall LO, et al. SMOTE: synthetic minority over-sampling technique. J Artif Intell Res. 2002;16:321–357.
  • Sun Y, Wong AK, Kamel MS. Classification of imbalanced data: a review. Intern J Pattern Recognit Artif Intell. 2009;23:687–719.
  • Alghamdi M, Al-Mallah M, Keteyian S, et al. Predicting diabetes mellitus using SMOTE and ensemble machine learning approach: the Henry Ford exercise testing (FIT) project. PLoS One. 2017;12:e0179805.
  • Cava W, Bauer C, Moore JH, et al. Interpretation of machine learning predictions for patient outcomes in electronic health records. AMIA Annu Symp Proc. 2020;2019:572–581.
  • Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129(25Suppl 2):S49–73.
  • Khan H, Greene SJ, Fonarow GC, et al. Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial. Eur J Heart Fail. 2015;17:1022–1031.
  • Kwok CS, Rao SV, Gilchrist IC, et al. Relation of length of stay to unplanned readmissions for patients who undergo elective percutaneous coronary intervention. Am J Cardiol. 2019;123:33–43.
  • Rosen OZ, Fridman R, Rosen BT, et al. Medication adherence as a predictor of 30-day hospital readmissions. Patient Prefer Adherence. 2017 Apr 20;11:801–810.
  • Zhang Y, Kaplan CM, Baik SH, et al. Medication adherence and readmission after myocardial infarction in the Medicare population. Am J Manag Care. 2014;20:e498–505. PMID: 25651604.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.